Blood-based biomarkers for Alzheimer’s present complex challenges to health care system

News
Written By Emily Scholler
Emily Scholler
Previous

VJNeurology Webinar: Translating Novel Diagnostics into Practice: Updates for Neurodegenerative Diseases.
Next

CEOi submits letter to CMS in response to their proposed reimbursement for brain health biomarkers